Eton Pharmaceuticals, Inc. ETON shares rallied 6.7% in the last trading session to close at $8.25. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 9.7% loss over the past four weeks.
The company recently reported first quarter earnings which came in-line with estimates. Investors are upbeat about the company’s first profitable quarter and launch of additional new products in the year.
Price and Consensus
This company is expected to post a quarterly loss of $0.14 per share in its upcoming report, which represents a year-over-year change of +39.1%. Revenues are expected to be $4.32 million, up 21485% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Eton Pharmaceuticals, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So make sure to keep an eye on ETON going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank 3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Eton Pharmaceuticals, Inc. (ETON) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research